Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of the Efficacy and Safety of BMS-512148 on Glycemic Control in Subjects With Type 2 Diabetes Treated Aggressively But Not Controlled on Combination Antihyperglycemic Therapy With Metformin and/or Thiazolidinedione (TZD) and Insulin.

NCT00357370 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00357370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00357370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of the Efficacy and Safety of BMS-512148 on Glycemic Control in Subjects With Type 2 Diabetes Treated Aggressively But Not Controlled on Combination Antihyperglycemic Therapy With Metformin and/or Thiazolidinedione (TZD) and Insulin.
Lead sponsor
AstraZeneca
Phase
Phase 2/3
Overall status
Completed
Start date
October 31, 2006
Completion date
March 31, 2008
Enrollment
163 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes